Daxor (DXR) Competitors $11.98 +0.24 (+2.04%) As of 12:40 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock DXR vs. STSS, AVR, CV, INFU, ELMD, BSGM, STIM, SGHT, KRMD, and CVRXShould you be buying Daxor stock or one of its competitors? The main competitors of Daxor include Sharps Technology (STSS), Anteris Technologies Global (AVR), CapsoVision (CV), InfuSystem (INFU), Electromed (ELMD), Biosig Technologies (BSGM), Neuronetics (STIM), Sight Sciences (SGHT), KORU Medical Systems (KRMD), and CVRx (CVRX). These companies are all part of the "medical equipment" industry. Daxor vs. Its Competitors Sharps Technology Anteris Technologies Global CapsoVision InfuSystem Electromed Biosig Technologies Neuronetics Sight Sciences KORU Medical Systems CVRx Daxor (NASDAQ:DXR) and Sharps Technology (NASDAQ:STSS) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their earnings, valuation, risk, dividends, institutional ownership, media sentiment, profitability and analyst recommendations. Which has more risk and volatility, DXR or STSS? Daxor has a beta of -0.1, indicating that its stock price is 110% less volatile than the S&P 500. Comparatively, Sharps Technology has a beta of 2.31, indicating that its stock price is 131% more volatile than the S&P 500. Is DXR or STSS more profitable? Daxor's return on equity of 0.00% beat Sharps Technology's return on equity.Company Net Margins Return on Equity Return on Assets DaxorN/A N/A N/A Sharps Technology N/A -8.72%-5.30% Which has better earnings & valuation, DXR or STSS? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioDaxorN/AN/AN/AN/AN/ASharps TechnologyN/AN/A-$9.30M-$1.21 thousand-0.01 Do analysts rate DXR or STSS? Daxor presently has a consensus target price of $25.00, suggesting a potential upside of 108.68%. Given Daxor's stronger consensus rating and higher possible upside, equities research analysts clearly believe Daxor is more favorable than Sharps Technology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Daxor 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Sharps Technology 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders hold more shares of DXR or STSS? 1.3% of Daxor shares are held by institutional investors. Comparatively, 17.2% of Sharps Technology shares are held by institutional investors. 59.5% of Daxor shares are held by insiders. Comparatively, 0.2% of Sharps Technology shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth. Does the media prefer DXR or STSS? In the previous week, Daxor had 3 more articles in the media than Sharps Technology. MarketBeat recorded 5 mentions for Daxor and 2 mentions for Sharps Technology. Daxor's average media sentiment score of 0.78 beat Sharps Technology's score of 0.63 indicating that Daxor is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Daxor 1 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Sharps Technology 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive SummaryDaxor beats Sharps Technology on 8 of the 10 factors compared between the two stocks. Get Daxor News Delivered to You Automatically Sign up to receive the latest news and ratings for DXR and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding DXR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart DXR vs. The Competition Export to ExcelMetricDaxorMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$56.78M$4.23B$5.75B$10.39BDividend YieldN/A1.27%5.75%4.64%P/E RatioN/A28.0575.7726.11Price / SalesN/A211.79544.74124.93Price / CashN/A27.9537.5461.24Price / BookN/A4.6612.876.30Net IncomeN/A$197.51M$3.29B$271.03M7 Day Performance5.09%0.21%-0.26%-0.15%1 Month Performance10.41%1.18%3.84%6.41%1 Year Performance30.36%19.63%68.35%28.81% Daxor Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)DXRDaxor3.8485 of 5 stars$11.98+2.0%$25.00+108.7%+25.2%$56.78MN/A0.0037Gap UpSTSSSharps Technology0.4653 of 5 stars$8.41-0.7%N/AN/A$217.77MN/A-0.013AVRAnteris Technologies Global1.577 of 5 stars$5.93+3.9%$16.50+178.2%N/A$213.84M$2.70M0.00138CVCapsoVisionN/A$4.44-0.9%$5.50+23.9%N/A$207.66MN/A0.0090INFUInfuSystem4.1538 of 5 stars$10.02-0.8%$12.50+24.8%+64.0%$204.77M$139.89M167.11410News CoverageAnalyst ForecastELMDElectromed3.8735 of 5 stars$24.25-0.6%$36.25+49.5%+16.7%$202.71M$64M32.37160Positive NewsBSGMBiosig Technologies1.6144 of 5 stars$6.35+42.6%$10.00+57.6%+1,885.4%$199.35M$13K0.0050Gap DownHigh Trading VolumeSTIMNeuronetics1.663 of 5 stars$2.84+2.6%$7.00+146.2%+232.1%$187.85M$74.89M-2.51180SGHTSight Sciences3.5204 of 5 stars$3.53+1.1%$4.42+25.1%-45.6%$184.60M$79.87M-3.67210KRMDKORU Medical Systems2.3572 of 5 stars$4.03+0.3%$4.63+14.7%+47.4%$183.80M$33.65M-44.1780CVRXCVRx2.7382 of 5 stars$6.88-1.0%$14.00+103.5%-17.7%$179.78M$51.29M-3.27160 Related Companies and Tools Related Companies Sharps Technology Alternatives Anteris Technologies Global Alternatives CapsoVision Alternatives InfuSystem Alternatives Electromed Alternatives Biosig Technologies Alternatives Neuronetics Alternatives Sight Sciences Alternatives KORU Medical Systems Alternatives CVRx Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:DXR) was last updated on 9/25/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Daxor Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Daxor With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free DXR Stock Alerts